[Treatment of myasthenia].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000628:therapy; D011379:Prognosis; D013449:Sulfonamides / Q000009:adverse effects; D013934:Thymectomy; D013965:Thyroidectomy / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D002800:Cholinesterase Inhibitors; D013449:Sulfonamides; D014149:Tranquilizing Agents; D000324:Adrenocorticotropic Hormone
Traitement de la myasthénie.